LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow System designed for venous arterialization of the lower limbs in end-stage patients at risk of limb...
Stents Peripheral
-
-
-
August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L.
-
It is estimated that more than 10 million people in the United States are affected by peripheral...
News | Stents Peripheral | April 28, 2017
April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world...
News | Stents Peripheral | March 16, 2017
March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...
News | Stents Peripheral | March 02, 2017
March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the...
News | Stents Peripheral | December 13, 2016
December 13, 2016 — Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18...
News | Stents Peripheral | December 08, 2016
December 8, 2016 — LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow...
Feature | Cath Lab | September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first...
The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves.
Feature | August 05, 2016 | Dave Fornell
August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...
The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.
Technology | Stents Peripheral | August 02, 2016
August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...
News | Peripheral Arterial Disease (PAD) | June 07, 2016
June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III)...
Technology | Stents Peripheral | April 27, 2016
April 27, 2016 — Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a...
News | Peripheral Arterial Disease (PAD) | March 22, 2016
March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II...
News | Stents Peripheral | March 17, 2016
March 17, 2016 — Boston Scientific announced in late February that the Eluvia Drug-Eluting Vascular Stent System...
The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.
Feature | Peripheral Arterial Disease (PAD) | February 22, 2016 | Dave Fornell
It is estimated that more than 10 million people in the United States are affected by...
Technology | Stents Peripheral | February 17, 2016
February 17, 2016 — Biotronik announced a partnership with Maquet Medical Systems USA to distribute Biotronik...
